Results from first human clinical trial offer promising early results for new Alzheimer's treatment - Medical Xpress
medicalxpress.comSubmitted by medicalxpress5525 in health
Alzheimer's disease is the most common cause of dementia, affecting more than 55 million people worldwide. Currently, the two main approaches for treatments to delay or slow its progression target the buildup of amyloid beta peptides—which form plaques in the…